A Clinical Risk Score for Prediction of Stent Thrombosis

American Journal of Cardiology

Volumn 102, Issue 5, 2008, Pages 541-545

  Baran, Kenneth W ^a   Lasala, John M ^b   Cox, David A ^c   Song, Aijun ^d   Deshpande, Mahesh C ^d   Jacoski, Mary V ^d   Mascioli, Stephen R ^d  

^a St Paul Heart Clinic   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Pain Specialists of Greater Lehigh Valley   (United States)

^d BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

'TAXUS'; CLOPIDOGREL; INSULIN; PACLITAXEL; THIENOPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AGED; ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTERY DIAMETER; ARTICLE; CARDIAC PATIENT; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG ELUTING STENT; DRUG WITHDRAWAL; FEMALE; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; THROMBOSIS; TREATMENT WITHDRAWAL;

BLOOD VESSEL PROSTHESIS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; STENTS; UNITED STATES;

EID: 51749093948     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.04.068     Document Type: Article

References (17)

1. Gottschall C.A.M., Quadros A.S., and Sarmento-Leite R. Acute coronary syndromes: predictive score for target vessel revascularization after bare metal coronary stenting. J Invasive Cardiol 18 (2006) 22-26
2. Singh M., Lennon R.J., Holmes D.R., Bell M.R., and Rihal C.S. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 40 (2002) 387-393
3. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
4. Waksman R., Buch A.N., Torguson R., Xue Z., Smith K., Javaid A., Chu W.W., Satler L.F., Kent K.M., and Pichard A.O. Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry). Am J Cardiol 100 (2007) 45-51
5. Urban P., Gershlick A.H., Guagliumi G., Guyon P., Lotan C., Schofer J., Seth A., Sousa J.E., Wijns W., Berge C., Deme M., and Stoll H.-P. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher Registry. Circulation 113 (2006) 1434-1441
6. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.-A., Steg P.G., Morel M.-A., Mauri L., Vranckx P., et al., Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
7. Lasala JM, Cox DA, Dobies D, Muhlestein JB, Katopodis JN, Revtyak G, Baim DS; for the ARRIVE 1 Participating Physicians. Usage patterns and 2-year outcomes with the Taxus Express stent: results of the U.S. ARRIVE 1 registry. Catheter Cardiovasc Interv. Epub ahead of print, April 21, 2008. doi:10.1002/ccd.21618.
8. Win H.K., Caldera A.E., Maresh K., Lopez J., Rihal C.S., Parikh M.A., Granada J.F., Marulkar S., Nassif D., Cohen D.J., Kleiman N.S., and EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009
9. Hioki Y., Aoki N., Kawano K., Homori M., Hasumura Y., Yasumura T., Maki A., Yoshino H., Yanagisawa A., and Ishikawa K. Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 22 (2001) 56-61
10. Machecourt J., Danchin N., Lablanche J.M., Fauvel J.M., Bonnet J.L., Marliere S., Foote A., Quesada J.L., Eltchaninoff H., Vanzetto G., and EVASTENT Investigators. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients; the EVASTENT matched-cohort registry. J Am Coll Cardiol 50 (2007) 501-508
11. Park D.-W., Park S.-W., Park K.-H., Lee B.-K., Kim Y.-H., Lee C.W., Hong M.-K., Kim J.-J., and Park S.-J. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98 (2006) 352-356
12. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., Kramer J.M., Harrington R.A., Matchar D.B., Kandzari D.E., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297 (2007) 159-168
13. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C., and BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
14. Spertus J.A., Kettelkamp R., Vance C., Decker C., Jones P.G., Rumsfeld J.S., Messenger J.C., Khanal S., Peterson E.D., Bach R.G., Krumholz H.M., and Cohen D.J. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006) 2803-2809
15. Ong A.T., McFadden E.P., Regar E., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Late Angiographic Stent Thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
16. King S.B., Smith S.C., Hirshfeld J.W., Jacobs A.K., Morrison D.A., and Williams D.O. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 117 (2008) 261-295
17. Lasala J.M., Cox D.A., Mascioli S.R., Baim D.S., and ARRIVE Participating Physicians. Predictors for stent thrombosis in real-world use of the Taxus Express2 paclitaxel-eluting stent: insights from the 7000-patient ARRIVE program. Presented at Transcatheter Cardiovascular Therapeutics. Washington, DC, October 22 (2007). http://www.aievolution.com/tct0701/index.cfm?do=abs.pubSearchOptions TCT no. 536. Accessed June 6, 2008